Brief: Fibrobiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair In Preclinical Study Of Degenerative Joints
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Brief: Fibrobiologics Granted US Patent Covering The Use Of Fibroblasts
FibroBiologics gains on patent related to insulin-producing cell transplant technology
Fibrobiologics Inc reports results for the quarter ended June 30 - Earnings Summary
Fibrobiologics Inc expected to post a loss of 72 cents a share - Earnings Preview
Brief: Fibrobiologics Advances Patient Dosing For Phase 1/2 Clinical Trial Of Cywc628 For The Treatment Of Diabetic Foot Ulcers
Brief: Fibrobiologics Announces First Patients Dosed In Phase 1/2 Clinical Trial Evaluating Cywc628 For The Treatment Of Diabetic Foot Ulcers
Brief: Fibrobiologics Inc - Files Provisional Patent Application For Oral Fibroblast Therapeutics
Brief: FibroBiologics Advancing Development Of A Fibroblast Treatment For Hantavirus
Brief: Fibrobiologics Announces Release Of Cywc628 Drug Product For Phase 1/2 Diabetic Foot Ulcer Clinical Trial
Brief: FibroBiologics Compliant with All Nasdaq Listing Requirements
Brief: Fibrobiologics Inc - Enters Lease Termination Agreement With United Fire & Casualty On April 3, 2026 - SEC Filing
Brief: Fibrobiologics Announces Closing Of $3 Million Public Offering
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM